Klebsiella pneumoniae Phage M198 and Its Therapeutic Potential
Viruses · 15.01.2025 · 17 (1) · 115
DOI: 10.3390/v17010115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 15.01.2025. Verfasst von Lika Leshkasheli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, G. Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Bacteriophages, Phage Therapy, Klebsiella Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shota Rustaveli National Science Foundation, SHOTA RUSTAVELI NATIONAL SCIENCE FOUNDATION OF GEORGIA, ELIAVA FOUNDATION.
Abstract (Originalsprache)
The rapid worldwide spread of antibiotic resistance is quickly becoming an increasingly concerning problem for human healthcare. Non-antibiotic antibacterial agents are in high demand for many Gram-negative bacterial pathogens, including Klebsiella pneumoniae. Klebsiella-targeting phages are among the most promising alternative therapy options. They have already been successfully applied in a number of cases, and it is expected that the need for anti-Klebsiella phages will only increase in the future. This prospect highlights the need for well-characterized therapeutic phages. In this work, we describe a K. pneumoniae phage, which also infects strains of Klebsiella oxytoca. Here, we characterize phage M198 in terms of its biological and genetic properties. Since in some phage therapy cases, phages are administered in combination with antibiotics, here, we also screen for possible synergistic effects of combining phage M198 with six different antibiotics. We found that phage M198 has good lytic activity against clinical isolates; it does not have any indications of a temperate lifestyle, and it has synergistic potential when combined with some therapeutically relevant antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, G. Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia.
- Laboratory of General Microbiology, G. Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia.
- Faculty of Medicine, European University, 0141 Tbilisi, Georgia.
- Program of Ecology, Faculty of Natural Sciences and Medicine, Ilia State University, 0162 Tbilisi, Georgia.
- Department of Immunology and Microbiology, Faculty of Exact and Natural Sciences, Ivane Javakhishvili Tbilisi State University, 0179 Tbilisi, Georgia.
- Electron Microscopy Unit, G. Eliava Institute of Bacteriophages, Microbiology and Virology, 0160 Tbilisi, Georgia.
ORCID-Profile: Ia Kusradze, Darejan Bolkvadze, Maria Chichashvili, Elisabed Zaldastanishvili
Förderung
- Shota Rustaveli National Science Foundation
- SHOTA RUSTAVELI NATIONAL SCIENCE FOUNDATION OF GEORGIA
- ELIAVA FOUNDATION
Zitieren
APA
Leshkasheli, L., Kusradze, I., Bolkvadze, D., Askilashvili, L., Chichashvili, M., Tsertsvadze, G., & Zaldastanishvili, E. (2025). Klebsiella pneumoniae Phage M198 and Its Therapeutic Potential. Viruses, 17(1), 115. https://doi.org/10.3390/v17010115
Vancouver
Leshkasheli L, Kusradze I, Bolkvadze D, Askilashvili L, Chichashvili M, Tsertsvadze G, et al. Klebsiella pneumoniae Phage M198 and Its Therapeutic Potential. Viruses. 2025;17(1):115. doi:10.3390/v17010115
BibTeX
@article{Leshkasheli2025,
author = {Leshkasheli, Lika and Kusradze, Ia and Bolkvadze, Darejan and Askilashvili, Lia and Chichashvili, Maria and Tsertsvadze, Giorgi and Zaldastanishvili, Elisabed},
title = {Klebsiella pneumoniae Phage M198 and Its Therapeutic Potential},
journal = {Viruses},
year = {2025},
volume = {17},
number = {1},
pages = {115},
doi = {10.3390/v17010115}
}
EUVIMED